Investors
Investors

Sales & Reports  >

Novartis has delivered dynamic sales and earnings over the past 10 years. The following information provides more information on the strong financial performance of the company.

Full-year results Quarterly Reports Financial Spreadsheets Annual Reports 20F Reports SEC Filings

US Investor Relations Contacts  >

If you would like investor information, please visit our Novartis US Corporate website for a full list of investor relations contacts.

Share Data and Analysis   >

Learn more about the history and performance of Novartis shares on the NYSE and SWX, ownership details and dividend history.

 
 
 

NVS

Share Analysis
 
Information for investors on Novartis.com
 
 
 

NOVZn

Share Analysis
 
 
Information for investors on Novartis.com
 

The information in the press releases on these pages was factually accurate on the date of publication. These press releases remain on Novartis' website for historical purposes only. Novartis assumes no duty to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.

 

ABOUT US

We provide medicines to treat and prevent diseases, ease suffering, and improve quality of life.

OUR PRODUCTS


Novartis is recognized worldwide for bringing to market innovative medicines with improved efficacy and fewer side-effects.

COMPANY HISTORY


Novartis was created in 1996 with the merger of Sandoz and Ciba-Geigy.